                                EUROPEAN COMMISSION
                                                                Brussels, 27.10.2016
                                                                C(2016) 7059 final
                                                                        PUBLIC VERSION
                                                                      SIMPLIFIED MERGER
                                                                           PROCEDURE
                                                                To the notifying party
Dear Sirs,
Subject:        Case M. 8219 - CD&R / DRIVE DEVILBISS HEALTHCARE
                Commission decision pursuant to Article 6(1)(b) of Council Regulation (EC)
                                1                                                                             2
                No 139/2004 and Article 57 of the Agreement on the European Economic Area
1.      On 05.10.2016, the European Commission received notification of a proposed
        concentration pursuant to Article 4 of the Merger Regulation by which CD&R Reign
        Topco, Inc. ultimately controlled by Clayton, Dubilier & Rice, Inc. ("CD&R", USA)
        acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the
        whole of Medical Depot Holdings, Inc., doing business as Drive DeVilbiss Healthcare
        ("Drive", USA), by way of purchase of shares.3
2.      The business activities of the undertakings concerned are:
             <U+F02D> for CD&R: an equity investor in management buyouts, strategic minority equity
                 investments and other strategic investments through funds controlling a number of
                 portfolio companies which are active in a variety of economic sectors, globally.
             <U+F02D> for Drive: manufacturing and distribution of medical equipment, including mobility
                 products, sleep and respiratory products, beds, bariatric products, wheelchairs,
                 sleep surfaces and pressure prevention products, self-assist products, power
                 operated wheelchairs, rehabilitation products, patient room equipment, personal
                 care products and electrotherapy devices, predominantly for patients’ home care
                 needs, globally.
1       OJ L 24, 29.1.2004, p. 1 (the 'Merger Regulation'). With effect from 1 December 2009, the Treaty on the
        Functioning of the European Union ('TFEU') has introduced certain changes, such as the replacement of
        'Community' by 'Union' and 'common market' by 'internal market'. The terminology of the TFEU will be used
        throughout this decision.
2       OJ L 1, 3.1.1994, p. 3 (the 'EEA Agreement').
3       Publication in the Official Journal of the European Union No C 378, 14.10.2016, p. 22.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.

3. After examination of the notification, the European Commission has concluded that the
   notified operation falls within the scope of the Merger Regulation and of paragraph 5(b) of
   the Commission Notice on a simplified procedure for treatment of certain concentrations
   under Council Regulation (EC) No 139/2004.4
4. For the reasons set out in the Notice on a simplified procedure, the European Commission
   has decided not to oppose the notified operation and to declare it compatible with the
   internal market and with the EEA Agreement. This decision is adopted in application of
   Article 6(1)(b) of the Merger Regulation and Article 57 of the EEA Agreement.
                                                    For the Commission
                                                    (Signed)
                                                    Johannes LAITENBERGER
                                                    Director-General
4  OJ C 366, 14.12.2013, p. 5.
                                                  2
